These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32579403)

  • 1. Comparison of
    Li Y; Khamou M; Schaarschmidt BM; Umutlu L; Forsting M; Demircioglu A; Haubold J; Koch AK; Bruckmann NM; Sawicki LM; Herrmann K; Boone JH; Langhorst J
    Br J Radiol; 2020 Aug; 93(1112):20200167. PubMed ID: 32579403
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Li Y; Schaarschmidt B; Umutlu L; Forsting M; Demircioglu A; Koch AK; Martin O; Herrmann K; Juette H; Tannapfel A; Langhorst J
    Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):768-777. PubMed ID: 31650217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.
    Berry N; Sinha SK; Bhattacharya A; Prasad KK; Vaishnavi C; Vaiphei K; Samanta J; Prasada R; Dhaka N; Kochhar R
    Dig Dis Sci; 2018 Jun; 63(6):1541-1550. PubMed ID: 29564671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of Fecal Markers with Magnifying Endoscopic Stratification in Patients with Ulcerative Colitis Who Are in Clinical Remission.
    Mine S; Takeshima F; Akazawa Y; Matsushima K; Minami H; Yamaguchi N; Ohnita K; Isomoto H; Nakao K
    Digestion; 2018; 97(1):82-89. PubMed ID: 29393146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.
    Urushikubo J; Yanai S; Nakamura S; Kawasaki K; Akasaka R; Sato K; Toya Y; Asakura K; Gonai T; Sugai T; Matsumoto T
    World J Gastroenterol; 2018 Oct; 24(38):4384-4392. PubMed ID: 30344422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of capsule endoscopy and fecal biomarkers in small-bowel Crohn's disease to assess remission and predict relapse.
    Aggarwal V; Day AS; Connor S; Leach ST; Brown G; Singh R; Friedman A; Zekry A; Craig PI
    Gastrointest Endosc; 2017 Dec; 86(6):1070-1078. PubMed ID: 28947363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ulcerative colitis: correlation of the Rachmilewitz endoscopic activity index with fecal calprotectin, clinical activity, C-reactive protein, and blood leukocytes.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Renzulli P; Seibold F
    Inflamm Bowel Dis; 2009 Dec; 15(12):1851-8. PubMed ID: 19462421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of fecal calprotectin as a marker of intestinal inflammation in patients with ulcerative colitis.
    Önal İK; Beyazit Y; Şener B; Savuk B; Özer Etık D; Sayilir A; Öztaş E; Torun S; Özderın Özın Y; Tunç Demırel B; Ülker A; Dağli Ü
    Turk J Gastroenterol; 2012; 23(5):509-14. PubMed ID: 23161295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 4 neutrophil-derived proteins in feces as indicators of disease activity in ulcerative colitis.
    Langhorst J; Elsenbruch S; Mueller T; Rueffer A; Spahn G; Michalsen A; Dobos GJ
    Inflamm Bowel Dis; 2005 Dec; 11(12):1085-91. PubMed ID: 16306771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated fecal levels of eosinophil granule proteins predict collagenous colitis in patients referred to colonoscopy due to chronic non-bloody diarrhea.
    Wagner M; Sjöberg K; Vigren L; Olesen M; Benoni C; Toth E; Carlson M
    Scand J Gastroenterol; 2016 Jul; 51(7):835-41. PubMed ID: 26854205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis.
    Singh S; Ananthakrishnan AN; Nguyen NH; Cohen BL; Velayos FS; Weiss JM; Sultan S; Siddique SM; Adler J; Chachu KA;
    Gastroenterology; 2023 Mar; 164(3):344-372. PubMed ID: 36822736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal Lactoferrin, Calprotectin, PMN-elastase, CRP, and White Blood Cell Count as Indicators for Mucosal Healing and Clinical Course of Disease in Patients with Mild to Moderate Ulcerative Colitis: Post Hoc Analysis of a Prospective Clinical Trial.
    Langhorst J; Boone J; Lauche R; Rueffer A; Dobos G
    J Crohns Colitis; 2016 Jul; 10(7):786-94. PubMed ID: 26874351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal leukocyte proteins in inflammatory bowel disease and irritable bowel syndrome.
    Silberer H; Küppers B; Mickisch O; Baniewicz W; Drescher M; Traber L; Kempf A; Schmidt-Gayk H
    Clin Lab; 2005; 51(3-4):117-26. PubMed ID: 15819166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of fecal biomarkers for the diagnosis and management of inflammatory bowel disease.
    Kopylov U; Rosenfeld G; Bressler B; Seidman E
    Inflamm Bowel Dis; 2014 Apr; 20(4):742-56. PubMed ID: 24562174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of calgranulin-C (S100A12) and fecal zonulin as possible non-invasive markers in children with inflammatory bowel disease: a clinical study.
    Cenni S; Casertano M; Trani M; Pacella D; Martinelli M; Staiano A; Miele E; Strisciuglio C
    Eur J Pediatr; 2023 Mar; 182(3):1299-1308. PubMed ID: 36637538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
    Gisbert JP; Bermejo F; Pérez-Calle JL; Taxonera C; Vera I; McNicholl AG; Algaba A; López P; López-Palacios N; Calvo M; González-Lama Y; Carneros JA; Velasco M; Maté J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1190-8. PubMed ID: 19291780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.
    Saboury B; Salavati A; Brothers A; Basu S; Kwee TC; Lam MG; Hustinx R; Louis E; Torigian DA; Alavi A
    Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):605-14. PubMed ID: 24253895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of faecal calprotectin assay variability on the management of inflammatory bowel disease and potential role of faecal S100A12.
    Whitehead SJ; Ford C; Gama RM; Ali A; McKaig B; Waldron JL; Steed H; Brookes MJ
    J Clin Pathol; 2017 Dec; 70(12):1049-1056. PubMed ID: 28735301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.